$4.22
0.020.48%
At close: -
$4.22
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Cytek Biosciences (CTKB) Forecast
NewsEarningsCytek Biosciences (CTKB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Cytek Biosciences Stock Price, Quotes and Forecasts | NASDAQ:CTKB | Benzinga
Explore Cytek Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTKB.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cytek Biosciences (CTKB) stock?
You can purchase shares of Cytek Biosciences (NASDAQ:CTKB) through any online brokerage.
Who are Cytek Biosciences (CTKB) competitors?
Other companies in Cytek Biosciences’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solutions (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for Cytek Biosciences (CTKB) stock?
Cytek Biosciences has a consensus price target of $7.75.
What is the current price for Cytek Biosciences (CTKB)?
The stock price for Cytek Biosciences (NASDAQ: CTKB) is $4.22 last updated March 24, 2025 at 4:00 PM EDT.
Does Cytek Biosciences (CTKB) pay a dividend?
There are no upcoming dividends for Cytek Biosciences.
When is Cytek Biosciences (NASDAQ:CTKB) reporting earnings?
Cytek Biosciences’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Cytek Biosciences (CTKB) going to split?
There is no upcoming split for Cytek Biosciences.
What sector and industry does Cytek Biosciences (CTKB) operate in?
Cytek Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.